This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
▼
Friday, July 1, 2011
Lawyers and Doctors Agree: Hepatitis C is Likely Curable; Telaprevir-Incivek, Boceprevir-Victrelis
In this program, Dr. Lorenzo Rossaro, Chief of UC Davis Hepatology, introduces a newly FDA approved therapy for Hepatitis C. Series: "UC Grand Rounds"
No comments:
Post a Comment